Edition:
United Kingdom

Inflarx NV (IFRX.OQ)

IFRX.OQ on NASDAQ Stock Exchange Global Select Market

38.77USD
20 Apr 2018
Change (% chg)

$1.63 (+4.39%)
Prev Close
$37.14
Open
$37.49
Day's High
$39.00
Day's Low
$37.49
Volume
8,826
Avg. Vol
14,510
52-wk High
$39.00
52-wk Low
$14.50

Chart for

About

Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory... (more)

Overall

No Ratios Available.

Financials

  IFRX.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -- -- --
ROI: -- 1.58 14.38
ROE: -- 2.41 16.07

BRIEF-Inflarx Announces First Patient Enrolled In Phase Iib Trial With Lead Candidate Ifx-1 In Hidradenitis Suppurativa

* INFLARX ANNOUNCES FIRST PATIENT ENROLLED IN PHASE IIB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA Source text for Eikon: Further company coverage:

08 Mar 2018

BRIEF-Inflarx Receives IND Acceptance To Proceed With A Phase IIB Trial With Lead Candidate IFX-1 In Hidradenitis Suppurativa

* INFLARX RECEIVES IND ACCEPTANCE TO PROCEED WITH A PHASE IIB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA

09 Jan 2018

BRIEF-Ra Capital Management Reports 12.3 Pct Passive Stake In Inflarx Nv

* RA CAPITAL MANAGEMENT LLC REPORTS 12.3 PERCENT PASSIVE STAKE IN INFLARX NV AS OF NOVEMBER 8 - SEC FILING Source text: [http://bit.ly/2kmho2j] Further company coverage:

11 Dec 2017

Earnings vs. Estimates